Selective targeting of G-protein-coupled receptor subtypes with venom peptides

Acta Physiologica

Volumn 204, Issue 2, 2012, Pages 186-201

  Nareoja K ^a   Nasman J ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Muscarinic toxin; Receptor; Receptor ligand; Three finger toxin; Venom

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA LATROTOXIN; CARDIOTOXIN; CONOPRESSIN; CONOTOXIN; CONTULAKIN G; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; GAMMA BUNGAROTOXIN; LATROPHILIN; MAMBA INTESTINAL TOXIN; MUSCARINIC RECEPTOR; MUSCARINIC TOXIN; NEUROPEPTIDE; NEUROTOXIN; PHOSPHOLIPASE A2; PIRENZEPINE; PREPRODYNORPHIN; PREPROENKEPHALIN; SARAFOTOXIN S6A; SARAFOTOXIN S6B; SARAFOTOXIN S6C; SNAKE VENOM; THREE FINGER TOXIN; TOXIN; UNCLASSIFIED DRUG; VENOM;

ALLOSTERISM; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AUTORADIOGRAPHY; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CONUS SNAIL; CORPUS STRIATUM; CYTOLYSIS; ENTORHINAL CORTEX; EXOCYTOSIS; GENE EXPRESSION; HEMOLYSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; HYDROPHOBICITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; INTERNEURON; LIGAND BINDING; LOCOMOTION; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; OLFACTORY BULB; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; UPREGULATION; VOLTAGE CLAMP;

AMINO ACID SEQUENCE; ANIMALS; ELAPID VENOMS; ELAPIDAE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MUSCARINIC; REPTILIAN PROTEINS; VENOMS;

EID: 84855349798     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02305.x     Document Type: Review

References (147)

1. Adem, A. & Karlsson, E. 1997. Muscarinic receptor subtype selective toxins. Life Sci60, 1069-1076.
2. Adem, A., Åsblom, A., Johansson, G., Mbugua, P.M. & Karlsson, E. 1988. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta968, 340-345.
3. Aird, S.D., Womble, G.C., Yates, J.R. 3rd & Griffin, P.R. 1999. Primary structure of gamma-bungarotoxin, a new postsynaptic neurotoxin from venom of Bungarus multicinctus. Toxicon37, 609-625.
4. Albrand, J.P., Blackledge, M.J., Pascaud, F., Hollecker, M. & Marion, D. 1995. NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom. Biochemistry34, 5923-5937.
5. 2+-dependent pathways, triggers exocytosis of two pools of synaptic vesicles. J Biol Chem276, 44695-44703.
6. Atkins, A.R., Martin, R.C. & Smith, R. 1995. 1H NMR studies of sarafotoxin SRTb, a nonselective endothelin receptor agonist, and IRL 1620, an ETB receptor-specific agonist. Biochemistry34, 2026-2033.
7. Banerjee, Y., Mizuguchi, J., Iwanaga, S. & Kini, R.M. 2005. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity. J Biol Chem280, 42601-42611.
8. Bashkatova, V., Hornick, A., Vanin, A. & Prast, H. 2008. Antagonist of M1 muscarinic acetylcholine receptor prevents neurotoxicity induced by amphetamine via nitric oxide pathway. Ann N Y Acad Sci1139, 172-176.
9. Bevan, P. & Hiestand, P. 1983. Beta-RTX. A receptor-active protein from Russell's viper (Vipera russelli russelli) venom. J Biol Chem258, 5319-5326.
10. Birnbaumer, L. 1990. G proteins in signal transduction. Annu Rev Pharmacol Toxicol30, 675-705.
11. Bjarnadottir, T.K., Fredriksson, R. & Schioth, H.B. 2007. The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci64, 2104-2119.
12. Boisbouvier, J., Albrand, J.P., Blackledge, M., Jaquinod, M., Schweitz, H., Lazdunski, M. & Marion, D. 1998. A structural homologue of colipase in black mamba venom revealed by NMR floating disulphide bridge analysis. J Mol Biol283, 205-219.
13. Bradley, K.N. 2000. Muscarinic toxins from the green mamba. Pharmacol Ther85, 87-109.
14. Bullock, C.M., Li, J.D. & Zhou, Q.Y. 2004. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol65, 582-588.
15. Bylund, D.B. 1988. Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci9, 356-361.
16. Calvete, J.J., Sanz, L., Angulo, Y., Lomonte, B. & Gutierrez, J.M. 2009. Venoms, venomics, antivenomics. FEBS Lett583, 1736-1743.
17. Carsi, J.M. & Potter, L.T. 2000. m1-Toxin isotoxins from the green mamba (Dendroaspis angusticeps) that selectively block m1 muscarinic receptors. Toxicon38, 187-198.
18. Carsi, J.M., Valentine, H.H. & Potter, L.T. 1999. m2-Toxin: a selective ligand for M2 muscarinic receptors. Mol Pharmacol56, 933-937.
19. Caulfield, M.P. & Birdsall, N.J. 1998. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev50, 279-290.
20. Chang, C.C. & Lee, C.Y. 1963. Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action. Arch Int Pharmacodyn Ther144, 241-257.
21. Chang, L.S., Chung, C., Wu, B.N. & Yang, C.C. 2002. Characterization and gene organization of Taiwan banded krait (Bungarus multicinctus) gamma-bungarotoxin. J Protein Chem21, 223-229.
22. Chen, Z., Rogge, G., Hague, C., Alewood, D., Colless, B., Lewis, R.J. & Minneman, K.P. 2004. Subtype-selective noncompetitive or competitive inhibition of human alpha1-adrenergic receptors by rho-TIA. J Biol Chem279, 35326-35333.
23. Chen, J., Kuei, C., Sutton, S., Wilson, S., Yu, J., Kamme, F., Mazur, C., Lovenberg, T. & Liu, C. 2005. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol67, 2070-2076.
24. Cobb, S.R. & Davies, C.H. 2005. Cholinergic modulation of hippocampal cells and circuits. J Physiol562, 81-88.
25. Craig, A.G., Norberg, T., Griffin, D., Hoeger, C., Akhtar, M., Schmidt, K., Low, W., Dykert, J., Richelson, E., Navarro, V. et al. 1999. Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem274, 13752-13759.
26. Cruz, L.J., de Santos, V., Zafaralla, G.C., Ramilo, C.A., Zeikus, R., Gray, W.R. & Olivera, B.M. 1987. Invertebrate vasopressin/oxytocin homologs. Characterization of peptides from Conus geographus and Conus straitus venoms. J Biol Chem262, 15821-15824.
27. Cushman, D.W. & Ondetti, M.A. 1999. Design of angiotensin converting enzyme inhibitors. Nat Med5, 1110-1113.
28. 2+-independent alpha-latrotoxin-binding protein. J Biol Chem271, 23239-23245.
29. Dixon, R.A., Kobilka, B.K., Strader, D.J., Benovic, J.L., Dohlman, H.G., Frielle, T., Bolanowski, M.A., Bennett, C.D., Rands, E., Diehl, R.E. et al. 1986. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature321, 75-79.
30. Dobner, P.R. 2006. Neurotensin and pain modulation. Peptides27, 2405-2414.
31. Docherty, J.R. 2010. Subtypes of functional alpha1-adrenoceptor. Cell Mol Life Sci67, 405-417.
32. Ducancel, F., Rowan, E.G., Cassar, E., Harvey, A.L., Menez, A. & Boulain, J.C. 1991. Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon29, 516-520.
33. Dufton, M.J. & Hider, R.C. 1988. Structure and pharmacology of elapid cytotoxins. Pharmacol Ther36, 1-40.
34. Dutertre, S., Croker, D., Daly, N.L., Andersson, A., Muttenthaler, M., Lumsden, N.G., Craik, D.J., Alewood, P.F., Guillon, G. & Lewis, R.J. 2008. Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem283, 7100-7108.
35. Eglen, R.M., Choppin, A., Dillon, M.P. & Hegde, S. 1999. Muscarinic receptor ligands and their therapeutic potential. Curr Opin Chem Biol3, 426-432.
36. Eglen, R.M., Choppin, A. & Watson, N. 2001. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci22, 409-414.
37. Escoubas, P. & Rash, L. 2004. Tarantulas: eight-legged pharmacists and combinatorial chemists. Toxicon43, 555-574.
38. Ferreira, S.H. 1965. A bradykinin-potentiating factor (Bpf) present in the venom of Bothrops jararca. Br J Pharmacol Chemother24, 163-169.
39. Ferreira, S.H., Bartelt, D.C. & Greene, L.J. 1970. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry9, 2583-2593.
40. Ferreira, A.R., Furstenau, L., Blanco, C., Kornisiuk, E., Sanchez, G., Daroit, D., Castro e Silva, M., Cervenansky, C., Jerusalinsky, D. & Quillfeldt, J.A. 2003. Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat. Pharmacol Biochem Behav74, 411-415.
41. Föller, M., Mahmud, H., Qadri, S.M., Gu, S., Braun, M., Bobbala, D., Hocher, B. & Lang, F. 2010. Endothelin B receptor stimulation inhibits suicidal erythrocyte death. FASEB J24, 3351-3359.
42. Fredriksson, R., Lagerstrom, M.C., Lundin, L.G. & Schioth, H.B. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol63, 1256-1272.
43. Freedman, J.E. & Snyder, S.H. 1981. Vipoxin. A protein from Russell's viper venom with high affinity for biogenic amine receptors. J Biol Chem256, 13172-13179.
44. Fruchart-Gaillard, C., Mourier, G., Marquer, C., Menez, A. & Servent, D. 2006. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7. Mol Pharmacol69, 1641-1651.
45. Fruchart-Gaillard, C., Mourier, G., Marquer, C., Stura, E., Birdsall, N.J. & Servent, D. 2008. Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states. Mol Pharmacol74, 1554-1563.
46. Gentili, F., Pigini, M., Piergentili, A. & Giannella, M. 2007. Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes. Curr Top Med Chem7, 163-186.
47. Graybiel, A.M., Aosaki, T., Flaherty, A.W. & Kimura, M. 1994. The basal ganglia and adaptive motor control. Science265, 1826-1831.
48. Harris, J.B. 1985. Phospholipases in snake venoms and their effects on nerve and muscle. Pharmacol Ther31, 79-102.
49. Harvey, A.L., Kornisiuk, E., Bradley, K.N., Cervenansky, C., Duran, R., Adrover, M., Sanchez, G. & Jerusalinsky, D. 2002. Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors. Neurochem Res27, 1543-1554.
50. Heinrich, J.N., Butera, J.A., Carrick, T., Kramer, A., Kowal, D., Lock, T., Marquis, K.L., Pausch, M.H., Popiolek, M., Sun, S.C., Tseng, E., Uveges, A.J. & Mayer, S.C. 2009. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur J Pharmacol605, 53-56.
51. Ichtchenko, K., Khvotchev, M., Kiyatkin, N., Simpson, L., Sugita, S. & Sudhof, T.C. 1998. Alpha-latrotoxin action probed with recombinant toxin: receptors recruit alpha-latrotoxin but do not transduce an exocytotic signal. EMBO J17, 6188-6199.
52. Jerusalinsky, D., Kornisiuk, E., Alfaro, P., Quillfeldt, J., Alonso, M., Verde, E.R., Cervenansky, C. & Harvey, A. 1998. Muscarinic toxin selective for m4 receptors impairs memory in the rat. Neuroreport9, 1407-1411.
53. Jolkkonen, M., van Giersbergen, P.L., Hellman, U., Wernstedt, C. & Karlsson, E. 1994. A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett352, 91-94.
54. Jolkkonen, M., Van Giersbergen, P.L., Hellman, U., Wernstedt, C., Oras, A., Satyapan, N., Adem, A. & Karlsson, E. 1995. Muscarinic toxins from the black mamba Dendroaspis polylepis. Eur J Biochem234, 579-585.
55. Karlsson, E., Mbugua, P.M. & Rodriguez-Ithurralde, D. 1984. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps. J Physiol Paris79, 232-240.
56. Karlsson, E., Risinger, C., Jolkkonen, M., Wernstedt, C. & Adem, A. 1991. Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon29, 521-526.
57. Karlsson, E., Jolkkonen, M., Mulugeta, E., Onali, P. & Adem, A. 2000. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie82, 793-806.
58. Kawanabe, Y. & Nauli, S.M. 2010. Endothelin. Cell Mol Life Sci68, 195-203.
59. Kedzierski, R.M. & Yanagisawa, M. 2001. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol41, 851-876.
60. Kern, S.E., Allen, J., Wagstaff, J., Shafer, S.L. & Yaksh, T. 2007. The pharmacokinetics of the conopeptide contulakin-G (CGX-1160) after intrathecal administration: an analysis of data from studies in beagles. Anesth Analg104, 1514-1520.
61. King, G.F., Gentz, M.C., Escoubas, P. & Nicholson, G.M. 2008. A rational nomenclature for naming peptide toxins from spiders and other venomous animals. Toxicon52, 264-276.
62. Kini, R.M. & Doley, R. 2010. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon56, 855-867.
63. Kloog, Y., Ambar, I., Sokolovsky, M., Kochva, E., Wollberg, Z. & Bdolah, A. 1988. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science242, 268-270.
64. Koivula, K., Rondinelli, S. & Näsman, J. 2010. The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist. Toxicon56, 440-447.
65. Kornisiuk, E., Jerusalinsky, D., Cervenansky, C. & Harvey, A.L. 1995. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon33, 11-18.
66. Krajewski, J.L., Dickerson, I.M. & Potter, L.T. 2001. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors. Mol Pharmacol60, 725-731.
67. Krasnoperov, V.G., Bittner, M.A., Beavis, R., Kuang, Y., Salnikow, K.V., Chepurny, O.G., Little, A.R., Plotnikov, A.N., Wu, D., Holz, R.W. & Petrenko, A.G. 1997. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron18, 925-937.
68. Kukhtina, V.V., Weise, C., Muranova, T.A., Starkov, V.G., Franke, P., Hucho, F., Wnendt, S., Gillen, C., Tsetlin, V.I. & Utkin, Y.N. 2000. Muscarinic toxin-like proteins from cobra venom. Eur J Biochem267, 6784-6789.
69. Kukkonen, A., Peräkylä, M., Åkerman, K.E. & Näsman, J. 2004. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. J Biol Chem279, 50923-50929.
70. 2+-independent insulin exocytosis induced by alpha-latrotoxin requires latrophilin, a G protein-coupled receptor. EMBO J17, 648-657.
71. Langmead, C.J., Watson, J. & Reavill, C. 2008. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther117, 232-243.
72. Lauer-Fields, J.L., Cudic, M., Wei, S., Mari, F., Fields, G.B. & Brew, K. 2007. Engineered sarafotoxins as tissue inhibitor of metalloproteinases-like matrix metalloproteinase inhibitors. J Biol Chem282, 26948-26955.
73. Lefkowitz, R.J. 2000. The superfamily of heptahelical receptors. Nat Cell Biol2, E133-E136.
74. Li, J., Zhang, H., Liu, J. & Xu, K. 2006. Novel genes encoding six kinds of three-finger toxins in Ophiophagus hannah (king cobra) and function characterization of two recombinant long-chain neurotoxins. Biochem J398, 233-242.
75. Liang, J.S., Carsi-Gabrenas, J., Krajewski, J.L., McCafferty, J.M., Purkerson, S.L., Santiago, M.P., Strauss, W.L., Valentine, H.H. & Potter, L.T. 1996. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon34, 1257-1267.
76. Liang, J., Gutierrez-Ford, C. & Potter, L.T. 2001. Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo. Brain Res921, 211-218.
77. Lin, D.C., Bullock, C.M., Ehlert, F.J., Chen, J.L., Tian, H. & Zhou, Q.Y. 2002. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem277, 19276-19280.
78. Link, R.E., Desai, K., Hein, L., Stevens, M.E., Chruscinski, A., Bernstein, D., Barsh, G.S. & Kobilka, B.K. 1996. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science273, 803-805.
79. Longenecker, H.E.Jr, Hurlbut, W.P., Mauro, A. & Clark, A.W. 1970. Effects of black widow spider venom on the frog neuromuscular junction. Effects on end-plate potential, miniature end-plate potential and nerve terminal spike. Nature225, 701-703.
80. Lorenz, W., Lomasney, J.W., Collins, S., Regan, J.W., Caron, M.G. & Lefkowitz, R.J. 1990. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification. Mol Pharmacol38, 599-603.
81. Makaritsis, K.P., Handy, D.E., Johns, C., Kobilka, B., Gavras, I. & Gavras, H. 1999. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension33, 14-17.
82. Marino, M.J., Rouse, S.T., Levey, A.I., Potter, L.T. & Conn, P.J. 1998. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci U S A95, 11465-11470.
83. Markram, H. & Segal, M. 1992. The inositol 1, 4, 5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA. J Physiol447, 513-533.
84. Masuda, Y., Takatsu, Y., Terao, Y., Kumano, S., Ishibashi, Y., Suenaga, M., Abe, M., Fukusumi, S., Watanabe, T., Shintani, Y. et al. 2002. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun293, 396-402.
85. Matsushita, H., Lelianova, V.G. & Ushkaryov, Y.A. 1999. The latrophilin family: multiply spliced G protein-coupled receptors with differential tissue distribution. FEBS Lett443, 348-352.
86. Max, S.I., Liang, J.S. & Potter, L.T. 1993a. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci13, 4293-4300.
87. Max, S.I., Liang, J.S. & Potter, L.T. 1993b. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol44, 1171-1175.
88. McDowell, R.S., Dennis, M.S., Louie, A., Shuster, M., Mulkerrin, M.G. & Lazarus, R.A. 1992. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry31, 4766-4772.
89. McIntosh, J.M., Santos, A.D. & Olivera, B.M. 1999. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem68, 59-88.
90. Menez, A., Gatineau, E., Roumestand, C., Harvey, A.L., Mouawad, L., Gilquin, B. & Toma, F. 1990. Do cardiotoxins possess a functional site? Structural and chemical modification studies reveal the functional site of the cardiotoxin from Naja nigricollis. Biochimie72, 575-588.
91. Miyoshi, S. & Tu, A.T. 1996. Phospholipase A2 from Naja naja sputatrix venom is a muscarinic acetylcholine receptor inhibitor. Arch Biochem Biophys328, 17-25.
92. Miyoshi, S. & Tu, A.T. 1999. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Arch Biochem Biophys369, 114-118.
93. Mollay, C., Wechselberger, C., Mignogna, G., Negri, L., Melchiorri, P., Barra, D. & Kreil, G. 1999. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol374, 189-196.
94. Mordvintsev, D.Y., Rodionov, D.I., Makarova, M.V., Kamensky, A.A., Levitskaya, N.G., Ogay, A.Y., Rzhevsky, D.I., Murashev, A.N., Tsetlin, V.I. & Utkin, Y.N. 2007. Behavioural effects in mice and intoxication symptomatology of weak neurotoxin from cobra Naja kaouthia. Basic Clin Pharmacol Toxicol100, 273-278.
95. Mordvintsev, D.Y., Polyak, Y.L., Rodionov, D.I., Jakubik, J., Dolezal, V., Karlsson, E., Tsetlin, V.I. & Utkin, Y.N. 2009. Weak toxin WTX from Naja kaouthia cobra venom interacts with both nicotinic and muscarinic acetylcholine receptors. FEBS J276, 5065-5075.
96. Mourier, G., Dutertre, S., Fruchart-Gaillard, C., Menez, A. & Servent, D. 2003. Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol Pharmacol63, 26-35.
97. Mulugeta, E., Karlsson, E., Islam, A., Kalaria, R., Mangat, H., Winblad, B. & Adem, A. 2003. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients. Brain Res960, 259-262.
98. Mulugeta, E., Chandranath, I., Karlsson, E., Winblad, B. & Adem, A. 2006. Temporal and region-dependent changes in muscarinic M4 receptors in the hippocampus and entorhinal cortex of adrenalectomized rats. Exp Brain Res173, 309-317.
99. Näsman, J., Jolkkonen, M., Ammoun, S., Karlsson, E. & Åkerman, K.E. 2000. Recombinant expression of a selective blocker of M(1) muscarinic receptors. Biochem Biophys Res Commun271, 435-439.
100. Negri, L., Lattanzi, R., Giannini, E. & Melchiorri, P. 2007. Bv8/Prokineticin proteins and their receptors. Life Sci81, 1103-1116.
101. Nirthanan, S. & Gwee, M.C. 2004. Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on. J Pharmacol Sci94, 1-17.
102. Nirthanan, S., Gopalakrishnakone, P., Gwee, M.C., Khoo, H.E. & Kini, R.M. 2003. Non-conventional toxins from Elapid venoms. Toxicon41, 397-407.
103. Oki, T., Takagi, Y., Inagaki, S., Taketo, M.M., Manabe, T., Matsui, M. & Yamada, S. 2005. Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. Brain Res Mol Brain Res133, 6-11.
104. Olianas, M.C., Adem, A., Karlsson, E. & Onali, P. 1996. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Br J Pharmacol118, 283-288.
105. Olianas, M.C., Ingianni, A., Maullu, C., Adem, A., Karlsson, E. & Onali, P. 1999. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. J Pharmacol Exp Ther288, 164-170.
106. Olianas, M.C., Maullu, C., Adem, A., Mulugeta, E., Karlsson, E. & Onali, P. 2000. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br J Pharmacol131, 447-452.
107. Olianas, M.C., Adem, A., Karlsson, E. & Onali, P. 2004. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors. Eur J Pharmacol487, 65-72.
108. Onali, P. & Olianas, M.C. 1998. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex. J Pharmacol Exp Ther286, 753-759.
109. Ondetti, M.A., Williams, N.J., Sabo, E.F., Pluscec, J., Weaver, E.R. & Kocy, O. 1971. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry10, 4033-4039.
110. Perez-Burgos, A., Perez-Rosello, T., Salgado, H., Flores-Barrera, E., Prieto, G.A., Figueroa, A., Galarraga, E. & Bargas, J. 2008. Muscarinic M(1) modulation of N and L types of calcium channels is mediated by protein kinase C in neostriatal neurons. Neuroscience155, 1079-1097.
111. 2+ channels. J Neurophysiol93, 2507-2519.
112. Poh, S.L., Mourier, G., Thai, R., Armugam, A., Molgo, J., Servent, D., Jeyaseelan, K. & Menez, A. 2002. A synthetic weak neurotoxin binds with low affinity to Torpedo and chicken alpha7 nicotinic acetylcholine receptors. Eur J Biochem269, 4247-4256.
113. +-channels. Eur J Biochem264, 287-300.
114. Power, A.E., Vazdarjanova, A. & McGaugh, J.L. 2003. Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem80, 178-193.
115. Purkerson, S.L. & Potter, L.T. 1998. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. J Pharmacol Exp Ther284, 707-713.
116. Quinton, L., Girard, E., Maiga, A., Rekik, M., Lluel, P., Masuyer, G., Larregola, M., Marquer, C., Ciolek, J., Magnin, T. et al. 2010. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha(1A)-adrenoceptor. Br J Pharmacol159, 316-325.
117. Raddatz, R., Schaffhauser, H. & Marino, M.J. 2007. Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessment. Biochem Pharmacol74, 383-391.
118. Rajagopalan, N., Pung, Y.F., Zhu, Y.Z., Wong, P.T., Kumar, P.P. & Kini, R.M. 2007. Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity. FASEB J21, 3685-3695.
119. Rohrer, D.K. & Kobilka, B.K. 1998. Insights from in vivo modification of adrenergic receptor gene expression. Annu Rev Pharmacol Toxicol38, 351-373.
120. Rosenthal, L. & Meldolesi, J. 1989. Alpha-latrotoxin and related toxins. Pharmacol Ther42, 115-134.
121. Rouget, C., Quinton, L., Maiga, A., Gales, C., Masuyer, G., Malosse, C., Chamot-Rooke, J., Thai, R., Mourier, G., De Pauw, E., Gilles, N. & Servent, D. 2010. Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the alpha(2) -adrenoceptors. Br J Pharmacol161, 1351-1360.
122. Russell, F.D. & Davenport, A.P. 1996. Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol119, 631-636.
123. Sanchez, G., Alvares Lde, O., Oberholzer, M.V., Genro, B., Quillfeldt, J., da Costa, J.C., Cervenansky, C., Jerusalinsky, D. & Kornisiuk, E. 2009. M4 muscarinic receptors are involved in modulation of neurotransmission at synapses of Schaffer collaterals on CA1 hippocampal neurons in rats. J Neurosci Res87, 691-700.
124. Santiago, M.P. & Potter, L.T. 2001. Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons. Brain Res894, 12-20.
125. Schaloske, R.H. & Dennis, E.A. 2006. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta1761, 1246-1259.
126. Scheinin, M., Lomasney, J.W., Hayden-Hixson, D.M., Schambra, U.B., Caron, M.G., Lefkowitz, R.J. & Fremeau, R.T.Jr 1994. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res21, 133-149.
127. Schweitz, H., Pacaud, P., Diochot, S., Moinier, D. & Lazdunski, M. 1999. MIT(1), a black mamba toxin with a new and highly potent activity on intestinal contraction. FEBS Lett461, 183-188.
128. Sharpe, I.A., Gehrmann, J., Loughnan, M.L., Thomas, L., Adams, D.A., Atkins, A., Palant, E., Craik, D.J., Adams, D.J., Alewood, P.F. & Lewis, R.J. 2001. Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nat Neurosci4, 902-907.
129. Sharpe, I.A., Thomas, L., Loughnan, M., Motin, L., Palant, E., Croker, D.E., Alewood, D., Chen, S., Graham, R.M., Alewood, P.F., Adams, D.J. & Lewis, R.J. 2003. Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA. J Biol Chem278, 34451-34457.
130. Silva, J.P., Suckling, J. & Ushkaryov, Y. 2009. Penelope's web: using alpha-latrotoxin to untangle the mysteries of exocytosis. J Neurochem111, 275-290.
131. Soga, T., Matsumoto, S., Oda, T., Saito, T., Hiyama, H., Takasaki, J., Kamohara, M., Ohishi, T., Matsushime, H. & Furuichi, K. 2002. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta1579, 173-179.
132. Takasaki, C., Tamiya, N., Bdolah, A., Wollberg, Z. & Kochva, E. 1988. Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart. Toxicon26, 543-548.
133. Terlau, H. & Olivera, B.M. 2004. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev84, 41-68.
134. Tsetlin, V. 1999. Snake venom alpha-neurotoxins and other 'three-finger' proteins. Eur J Biochem264, 281-286.
135. Ushkaryov, Y. 2002. Alpha-latrotoxin: from structure to some functions. Toxicon40, 1-5.
136. Utkin, Y.N., Kukhtina, V.V., Kryukova, E.V., Chiodini, F., Bertrand, D., Methfessel, C. & Tsetlin, V.I. 2001. "Weak toxin" from Naja kaouthia is a nontoxic antagonist of alpha 7 and muscle-type nicotinic acetylcholine receptors. J Biol Chem276, 15810-15815.
137. Vandermeers, A., Vandermeers-Piret, M.-C., Rathé, J., Waelbroeck, M., Jolkkonen, M., Oras, A. & Karlsson, E. 1995. Purification and sequence determination of a new muscarinic toxin (MT4) from the venom of the green mamba (Dendroaspis angusticeps). Toxicon33, 1171-1179.
138. Vassilatis, D.K., Hohmann, J.G., Zeng, H., Li, F., Ranchalis, J.E., Mortrud, M.T., Brown, A., Rodriguez, S.S., Weller, J.R., Wright, A.C., Bergmann, J.E. & Gaitanaris, G.A. 2003. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA100, 4903-4908.
139. Vassilevski, A.A., Kozlov, S.A. & Grishin, E.V. 2009. Molecular diversity of spider venom. Biochemistry (Mosc)74, 1505-1534.
140. Volpicelli, L.A. & Levey, A.I. 2004. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res145, 59-66.
141. Wang, J.Q. & McGinty, J.F. 1996. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience75, 43-56.
142. Wang, J.Q., Jolkkonen, M. & McGinty, J.F. 1997. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Eur J Pharmacol334, 43-47.
143. de Weille, J.R., Schweitz, H., Maes, P., Tartar, A. & Lazdunski, M. 1991. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc Natl Acad Sci U S A88, 2437-2440.
144. Wen, S., Wilson, D.T., Kuruppu, S., Korsinczky, M.L., Hedrick, J., Pang, L., Szeto, T., Hodgson, W.C., Alewood, P.F. & Nicholson, G.M. 2005. Discovery of an MIT-like atracotoxin family: spider venom peptides that share sequence homology but not pharmacological properties with AVIT family proteins. Peptides26, 2412-2426.
145. Williams, D.L.Jr, Jones, K.L., Pettibone, D.J., Lis, E.V. & Clineschmidt, B.V. 1991. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun175, 556-561.
146. Wu, P.L., Lee, S.C., Chuang, C.C., Mori, S., Akakura, N., Wu, W.G. & Takada, Y. 2006. Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. J Biol Chem281, 7937-7945.
147. Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D. & Yanagisawa, M. 1994. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell78, 473-485.